This brand name is authorized in Austria, Ecuador, South Africa, Spain, Tunisia, UK.
The drug SCANLUX contains one active pharmaceutical ingredient (API):
1
|
UNII
9679TC07X4 - IODINE
|
|
Iopamidol is contrast medium belonging to the new generation of non-ionic compound whose solubility is due to the presence of hydrophilic substitutes in the molecule. This results in a solution of low osmollity when compared with ionic media. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| V08AB04 | Iopamidol | V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 1263-MEE-0815, 1555-MEE-1215 |
| ES | Centro de información online de medicamentos de la AEMPS | 71850, 71851 |
| GB | Medicines & Healthcare Products Regulatory Agency | 90672, 90687, 90707, 90715 |
| TN | Direction de la Pharmacie et du Médicament | 1803011, 1803012, 1803013, 1803014 |
| ZA | Health Products Regulatory Authority | 41/28/0429, 41/28/0430 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.